CDR-426D

N/A

Report date: 2022/05/10 11:43:45
NME

Base Information

Drug NameCDR-426D
Drug Alias NameCDR426D
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide
Mechanisms of ActionMicroRNAs inhibitors
TargetsMicroRNAs
Therapy Area/IndicationsCardiomyopathy, Dilated
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesHannover Medical School
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsCardiomyopathy, Dilated
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A